Q2 2019 13F Holders as of 30 Jun 2019
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
80,702,987
-
Total 13F shares
-
1,032,457
-
Share change
-
-81,741
-
Total reported value
-
$2,456,382
-
Put/Call ratio
-
54%
-
Price per share
-
$2.37
-
Number of holders
-
15
-
Value change
-
-$456,116
-
Number of buys
-
9
-
Number of sells
-
7
Institutional Holders of Altimmune, Inc. - Common Stock (ALT) as of Q2 2019
As of 30 Jun 2019,
Altimmune, Inc. - Common Stock (ALT) was held by
15 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
1,032,457 shares.
The largest 10 holders included
VANGUARD GROUP INC, MORGAN STANLEY, GEODE CAPITAL MANAGEMENT, LLC, DIMENSIONAL FUND ADVISORS LP, BANK OF AMERICA CORP /DE/, SUSQUEHANNA INTERNATIONAL GROUP, LLP, BlackRock Inc., SABBY MANAGEMENT, LLC, Bank of New York Mellon Corp, and CITADEL ADVISORS LLC.
This page lists
15
institutional shareholders reporting positions in this security
for the Q2 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.